Serum chemerin in patients with rheumatoid arthritis: can it unravel the Chimera of concomitant type 2 diabetes?
Enregistré dans:
| Auteur principal: | Dimitrios Patoulias |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Termedia Publishing House
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/2334f68ca9d2473a8e4486a937dcf0d7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Functional disability is related to serum chemerin levels in rheumatoid arthritis
par: Maria Luisa Vazquez-Villegas, et autres
Publié: (2021) -
Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis
par: Dunia Ali, et autres
Publié: (2020) -
Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
par: Fabiola Gonzalez-Ponce, et autres
Publié: (2021) -
The potential value of serum chemerin in patients with breast cancer
par: Yanfang Song, et autres
Publié: (2021) -
Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus
par: Elsehmawy AAEW, et autres
Publié: (2019)